← Back to Search

Group 1 for Breast Cancer

N/A
Waitlist Available
Led By Katharine L Szubski, BSN RN OCN
Research Sponsored by Advocate Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

The purpose of this study is to determine whether patients experience a better quality of life when they have received education about coping strategies for cognitive dysfunction.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
FACT-Cog 3 questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group 1Experimental Treatment1 Intervention
The research team will provide the intervention to subjects. Intervention: The nursing-driven Cognitive Dysfunction Coping Strategy Teaching Sheet and provide education as to its use. QOL survey administered
Group II: Group 2Active Control1 Intervention
Provide current standard of education for cognitive dysfunction. QOL survey administered

Find a Location

Who is running the clinical trial?

Advocate Health CareLead Sponsor
53 Previous Clinical Trials
1,510,932 Total Patients Enrolled
1 Trials studying Breast Cancer
1,341,172 Patients Enrolled for Breast Cancer
Katharine L Szubski, BSN RN OCNPrincipal InvestigatorAdvocate Health Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~7 spots leftby Apr 2025